mild moderate severe - dermaworld · mild 10% of body area. for some patients, plaque psoriasis is...
TRANSCRIPT
Plaque psoriasis diagnostic and monitoring tool
Teva 10 LEO Consultation ToolsLeigh –16 11 17 297 x 210 mm 100% Supplied 16.11.17
ARTWORK 20305 LEO GP Cons Tool A4P
Art Director ................................. Copy Writer................................. CD Copy..................................... CD Art .........................................Approved Comments Approved Comments Approved Comments Approved Comments
Producer .................................... Account Director ........................ Account Manager ...................... Planner ......................................Approved Comments Approved Comments Approved Comments Approved Comments
Body Surface Area (BSA) scale:2
Mild <3% of body area
Moderate 3-10% of body area
Severe >10% of body area
For some patients, plaque psoriasis is more than a skin disorder.
This tool can help you gain a better understanding by evaluating both physical and emotional impacts of their condition.
Remember:• ask about all of your patient’s plaques as
they can vary in severity across the body, including scalp and genital plaques
• carefully examine nails for cutaneous disease
• ask about joint stiffness as it may signal psoriatic arthritis
• plaques in some locations can limit activity and cause more pain than others, influencing assessment of severity
Plaque psoriasis images from DermNet NZ. Available from www.dermnetnz.org
UK/IE MAT-26724, July 2019.
Assessing physical impact
Physician Global Assessment (PGA) for plaque psoriasis:1 PGA describes severity as clear, almost clear, mild, moderate, severe and very severe.
Mild Moderate Severe
Moderate plaque elevation, scaling, and/or erythema
Very marked plaque elevation, scaling, and/or erythema
Slight plaque elevation, scaling, and/or erythema
1 side of a patient’s hand ~ 1% of their body surface area
PROMOTIONAL ITEM PRODUCED BY LEO PHARMA. ALL LEO TRADEMARKS BELONG TO THE LEO GROUP
Date of Preparation: July 2019. UK/IE MAT-26724
Teva 10 LEO Consultation ToolsLeigh –16 11 17 297 x 210 mm 100% Supplied 16.11.17
ARTWORK 20305 LEO GP Cons Tool A4P
Art Director ................................. Copy Writer ................................. CD Copy ..................................... CD Art .........................................Approved Comments Approved Comments Approved Comments Approved Comments
Producer .................................... Account Director ........................ Account Manager ...................... Planner ......................................Approved Comments Approved Comments Approved Comments Approved Comments
For a more comprehensive assessment, the Dermatology Life Quality Index (DLQI) can help you quantify the life impact of skin conditions. Available at: www.dermatology.org.uk
Are they taking days off work or study due to psoriasis?
Do they feel isolated from or misunderstood by loved ones?
Do they avoid activities they used to enjoy?
Do they feel embarrassed or low in confidence?
Do they experience low-energy or trouble sleeping?
Consider a referral when plaque psoriasis is:3
• severe or extensive, for example affecting >10% of the body surface area
• not responding to topical therapy
• present in the nails, with functional or cosmetic impact
• present with suspected psoriatic arthritis
• having a major impact on a person’s physical, psychological or social wellbeing
Treatment guidance for plaque psoriasis in a primary care setting is available from the Primary Care Dermatology Society, the leading dermatology society for GPs.4
Further guidance is available from NICE or SIGN clinical guidelines, or your local CCG.
References:
1. Cappelleri JC et al. Qual Life Res 2013;22(9):2489-2499
2. National Psoriasis Foundation. About psoriasis. Available from https://psoriasis.org/about-psoriasis. Last accessed: July 2019.
3. NICE Psoriasis Clinical Guideline CG153. Available from: https://www.nice.org.uk/guidance/cg153. Last accessed: July 2019.
4. PCDS Psoriasis Guideline. Available from: http://www.pcds.org.uk/clinical-guidance/psoriasis-anoverview. Last accessed: July 2019.
Assessing impact on quality of lifeAsk how their psoriasis is affecting different aspects of their life:3